MarketPeel
Insider Trading Intelligence
DS

David Schaffer

FDMT
DIRECTOR · 4D MOLECULAR THERAPEUTICS, INC. · CIK 0001692929
FILING MIX · LIFETIME12%/88%
BUYS
2
SELLS
15
TOTAL VALUE
$3.06M
COMPANIES
2
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
904,835
AVG SELL PX
$30.77
TRADE KIND
SHOWING 17 / 17
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
14 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by David Schaffer, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d14+92.86%-11.49%-0.12%-11.37%-11.34%
14d14+78.57%-11.62%+0.92%-12.54%-14.39%
30d14+85.71%-11.71%+3.67%-15.38%-17.92%
60d14+100.00%-28.14%+3.01%-31.15%-33.24%
90d14+92.86%-29.38%+6.26%-35.65%-38.67%
180d14+100.00%-48.71%+3.49%-52.20%-55.09%
1y14+100.00%-70.70%-13.35%-57.35%-57.28%
2y14+100.00%-60.09%+2.50%-62.59%-58.84%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
FDMT · 901,215 shares · as of Oct 22, 2021
0246,731493,463740,194986,925SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
FLOW · 2 buys / 15 sellsCOVERAGE · 8 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
1,900$31.00$58.9K901,215Oct 22, 2021Oct 22, 2021View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
22,820$31.56$720.2K903,115Oct 21, 2021Oct 22, 2021View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
11,565$31.02$358.8K925,935Oct 20, 2021Oct 22, 2021View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
4,549$27.28$124.1K937,500Sep 30, 2021Oct 1, 2021View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
7,836$26.69$209.2K942,049Sep 30, 2021Oct 1, 2021View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
8,365$29.06$243.1K950,585Sep 29, 2021Oct 1, 2021View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
700$30.06$21.0K949,885Sep 29, 2021Oct 1, 2021View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
7,806$27.99$218.5K958,950Sep 29, 2021Oct 1, 2021View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
100$32.00$3.2K966,756Sep 28, 2021Sep 29, 2021View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
13,812$30.52$421.5K966,856Sep 28, 2021Sep 29, 2021View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
13,075$32.59$426.1K986,925Sep 27, 2021Sep 29, 2021View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
100$34.19$3.4K980,668Sep 27, 2021Sep 29, 2021View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
6,157$33.51$206.3K980,768Sep 27, 2021Sep 29, 2021View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
22,50022,500May 17, 2021May 19, 2021View →
QURE
UNIQURE N.V.
SALEGRANT
Stock grant
2,06346,978Feb 27, 2020Mar 2, 2020View →
QURE
UNIQURE N.V.
PURCHASEGRANT
Stock grant
3,6203,620Feb 27, 2020Mar 2, 2020View →
QURE
UNIQURE N.V.
SALE
806$62.27$50.2K44,915Jan 28, 2020Jan 30, 2020View →
Other insiders · FDMT
Loading peer insiders…
About this filer
CIK 0001692929
ROLE
Director
PRIMARY
FDMT
COMPANIES
2
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001692929DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback